Literature DB >> 20085050

Intrahepatic pseudoaneurysm after radiofrequency ablation of liver lesion.

Rajiv V Datta1.   

Abstract

Radiofrequency ablation of the liver for primary and metastatic disease is used for patients who are not candidates for resection or in conjunction with resection. The technique is simple, and the morbidity rate is low. A case of intrahepatic pseudoaneurysm after radiofrequency ablation of a centrally located hepatocellular carcinoma in the right lobe of the liver is presented. A successful radiofrequency ablation was done under ultrasound control. Postablation computed tomography (CT) scans showed a 2.5-cm hypervascular enhancing lesion within the hypodense region of the ablation. This was compatible with pseudoaneurysm. The patient underwent hepatic angiography and successful embolization of the aneurysm with coils. A 12-month follow-up CT scan of the liver showed postablation changes with no evidence of recurrence or filling of the aneurysm. Radiofrequency ablation is a novel technique that is being used to treat hepatic lesions with an increasing frequency. Complications with this rapidly spreading technique should not be underestimated.

Entities:  

Mesh:

Year:  2008        PMID: 20085050

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  3 in total

1.  Intrahepatic pseudoaneurysm after radiofrequency ablation of liver metastases.

Authors:  Fiammetta Soggiu; Jacques Marescaux; Patrick Pessaux
Journal:  Hepatobiliary Surg Nutr       Date:  2014-08       Impact factor: 7.293

2.  Life-threatening hemorrhage after liver radiofrequency ablation successfully controlled by transarterial embolization.

Authors:  Xing-Yu Wu; Xiao-Lei Shi; Jian-Xin Zhou; Yu-Dong Qiu; Tie Zhou; Bing Han; Yi-Tao Ding
Journal:  World J Hepatol       Date:  2012-12-27

3.  Spontaneous resolution of asymptomatic hepatic pseudoaneurysm post radiofrequency ablation.

Authors:  Li Shyan Ch'ng; Estrellita Elena Mohd Tazuddin; Benny Young; Ahmad Faizal Mohd Ali
Journal:  BJR Case Rep       Date:  2016-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.